CD83 on murine APC does not function as a costimulatory receptor for T cells

Immunology Letters

Volumn 120, Issue 1-2, 2008, Pages 87-95

  Kretschmer, Birte ^a   Lüthje, Katja ^a   Ehrlich, Svenja ^a   Osterloh, Anke ^a   Piedavent, Melanie ^a   Fleischer, Bernhard ^a,b   Breloer, Minka ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Antigen presenting cells; CD83; Costimulation; T cell activation

Indexed keywords

CD83 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD86; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; RATS; RECEPTORS, ANTIGEN, T-CELL; SPLEEN;

EID: 50449109581     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.07.004     Document Type: Article

References (37)

1. Zhou L.J., Schwarting R., Smith H.M., and Tedder T.F. A novel cell-surface molecule expressed by human interdigitating reticulum cells, langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149 (1992) 735-742
2. Kozlow E.J., Wilson G.L., Fox C.H., and Kehrl J.H. Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood 81 (1993) 454-461
3. Twist C.J., Beier D.R., Disteche C.M., Edelhoff S., and Tedder T.F. The mouse Cd83 gene: structure, domain organization, and chromosome localization. Immunogenetics 48 (1998) 383-393
4. + cell. J Immunol 179 (2007) 5117-5125
5. Ohta Y., Landis E., Boulay T., Phillips R.B., Collet B., Secombes C.J., et al. Homologs of CD83 from elasmobranch and teleost fish. J Immunol 173 (2004) 4553-4560
6. Breloer M., and Fleischer B. CD83 regulates lymphocyte maturation, activation and homeostasis. Trends Immunol 29 (2008) 186-194
7. + T cell development in the thymus. Cell 108 (2002) 755-767
8. + T cells. J Immunol 173 (2004) 2995-3001
9. Luthje K., Cramer S.O., Ehrlich S., Veit A., Steeg C., Fleischer B., et al. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells. Eur J Immunol 36 (2006) 2035-2045
10. Berchtold S., Muhl-Zurbes P., Heufler C., Winklehner P., Schuler G., and Steinkasserer A. Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation. FEBS Lett 461 (1999) 211-216
11. Zhou L.J., and Tedder T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154 (1995) 3821-3835
12. Wolenski M., Cramer S.O., Ehrlich S., Steeg C., Grossschupff G., Tenner-Racz K., et al. Expression of CD83 in the murine immune system. Med Microbiol Immunol (Berl) 192 (2003) 189-192
13. McKinsey T.A., Chu Z., Tedder T.F., and Ballard D.W. Transcription factor NF-kappaB regulates inducible CD83 gene expression in activated T lymphocytes. Mol Immunol 37 (2000) 783-788
14. Breloer M., Kretschmer B., Luthje K., Ehrlich S., Ritter U., Bickert T., et al. CD83 is a regulator of murine B cell function in vivo. Eur J Immunol 37 (2007) 634-648
15. + T cell longevity in vivo. J Immunol 179 (2007) 4550-4562
16. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22 (2005) 329-341
17. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
18. + T cells modulates inflammation and autoimmunity. J Immunol 180 (2008) 5890-5897
19. Cao W., Lee S.H., and Lu J. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem J 385 (2005) 85-93
20. Iking-Konert C., Cseko C., Wagner C., Stegmaier S., Andrassy K., and Hansch G.M. Transdifferentiation of polymorphonuclear neutrophils: acquisition of CD83 and other functional characteristics of dendritic cells. J Mol Med 79 (2001) 464-474
21. Yamashiro S., Wang J.M., Yang D., Gong W.H., Kamohara H., and Yoshimura T. Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood 96 (2000) 3958-3963
22. + NK helper cells. J Exp Med 202 (2005) 941-953
23. Prechtel A.T., and Steinkasserer A. CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch Dermatol Res 299 (2007) 59-69
24. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
25. Lechmann M., Zinser E., Golka A., and Steinkasserer A. Role of CD83 in the immunomodulation of dendritic cells. Int Arch Allergy Immunol 129 (2002) 113-118
26. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2 (2002) 116-126
27. Kruse M., Rosorius O., Kratzer F., Bevec D., Kuhnt C., Steinkasserer A., et al. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J Exp Med 191 (2000) 1581-1590
28. Kruse M., Rosorius O., Kratzer F., Stelz G., Kuhnt C., Schuler G., et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol 74 (2000) 7127-7136
29. + T cells and preferential enrichment for antigen specificity. Blood 107 (2006) 1528-1536
30. Prechtel A.T., Turza N.M., Theodoridis A.A., and Steinkasserer A. CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J Immunol 178 (2007) 5454-5464
31. Aerts-Toegaert C., Heirman C., Tuyaerts S., Corthals J., Aerts J.L., Bonehill A., et al. CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol 37 (2007) 686-695
32. Yang S., Yang Y., Raycraft J., Zhang H., Kanan S., Guo Y., et al. Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137. Proc Natl Acad Sci USA 101 (2004) 4990-4995
33. Kretschmer B., Luthje K., Guse A.H., Ehrlich S., Koch-Nolte F., Haag F., et al. CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells. PLoS One 2 (2007) e755
34. Wolenski M., Cramer S.O., Ehrlich S., Steeg C., Fleischer B., and Von Bonin A. Enhanced activation of CD83-positive T cells. Scand J Immunol 58 (2003) 306-311
35. Cramer S.O., Trumpfheller C., Mehlhoop U., More S., Fleischer B., and von Bonin A. Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. Int Immunol 12 (2000) 1347-1351
36. Kuwano Y., Prazma C.M., Yazawa N., Watanabe R., Ishiura N., Kumanogoh A., et al. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. Int Immunol 19 (2007) 977-992
37. Zinser E., Lechmann M., Golka A., Lutz M.B., and Steinkasserer A. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J Exp Med 200 (2004) 345-351